Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Urologic Oncology
|
May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy
David D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
European Urology
|
February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
Brandon A Mahal, David D Yang, Natalie Q Wang, et al.
Radiology
|
October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer
David D Yang, Leslie K Lee, James M G Tsui, et al.
NPJ Precision Oncology
|
April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer
David D Chen, Anat Zimmer, David D Yang, et al.
Cancer Cell
|
January 16, 2026
A context-augmented large language model for accurate precision oncology medicine recommendations
Hyeji Jun, Yutaro Tanaka, Shreya Johri, et al.
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer
David D Yang, Aya Abdelnaser, Alexander J Haas, et al.
Cancer Immunology Research
|
March 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer
Atish D Choudhury, Lucia Kwak, Alexander Cheung, et al.
JCO Precision Oncology
|
July 8, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials
Christopher J Sweeney, Vrishab Krishna, Viswesh Krishna, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Urologic Oncology
|
May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy
David D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
European Urology
|
February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
Brandon A Mahal, David D Yang, Natalie Q Wang, et al.
Radiology
|
October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer
David D Yang, Leslie K Lee, James M G Tsui, et al.
NPJ Precision Oncology
|
April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer
David D Chen, Anat Zimmer, David D Yang, et al.
Cancer Cell
|
January 16, 2026
A context-augmented large language model for accurate precision oncology medicine recommendations
Hyeji Jun, Yutaro Tanaka, Shreya Johri, et al.
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer
David D Yang, Aya Abdelnaser, Alexander J Haas, et al.
Cancer Immunology Research
|
March 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer
Atish D Choudhury, Lucia Kwak, Alexander Cheung, et al.
JCO Precision Oncology
|
July 8, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials
Christopher J Sweeney, Vrishab Krishna, Viswesh Krishna, et al.
Page
of 5